Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07213531 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Enhanced Valves Interventions and Safe AI Generated End Results

Study acronym: ENVISAGE
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This non-interventional study aims to use artificial intelligence to improve the prediction of transcatheter heart valve interventions and optimize patient outcomes. It is based on the analysis of retrospective data from various specialized centers worldwide.
Trial Details
NCT Number NCT07213531
Lead Sponsor Montreal Heart Institute
Collaborators: Centre Hospitalier Universitaire de Bordeaux, FRANCE, Materialise, Pie Medical Imaging, Clinique Pasteur Toulouse, Centre Cardiologique du Nord, Rennes University Hospital, San Raffaele University Hospital, Italy, Istituto clinico Città di Brescia, Unity Health Toronto, University Hospital, Marseille, University Hospital, Lille, Hospitaux Universitaires Paris Sud, Montefiore Medical Center, University Medical Center Mainz, Universitätsklinikum Hamburg-Eppendorf, Vancouver Hospital
Conditions
(from sponsor)		 Heart Valve Disease, TAVI, M-TEER, TTVI, TMVI, T-TEER, Mitraclip, TriClip
Related terms Heart Valve Diseases
Enrollment 21,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov